Replicated methylation changes associated with eczema herpeticum and allergic response
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although epigenetic mechanisms are important risk factors for allergic disease, few studies have evaluated DNA methylation differences associated with atopic dermatitis (AD), and none has focused on AD with eczema herpeticum (ADEH+). We will determine how methylation varies in AD individuals with/without EH and associated traits. We modeled differences in genome-wide DNA methylation in whole blood cells from 90 ADEH+, 83 ADEH-, and 84 non-atopic, healthy control subjects, replicating in 36 ADEH+, 53 ADEH-, and 55 non-atopic healthy control subjects. We adjusted for cell-type composition in our models and used genome-wide and candidate-gene approaches. RESULTS: We replicated one CpG which was significantly differentially methylated by severity, with suggestive replication at four others showing differential methylation by phenotype or severity. Not adjusting for eosinophil content, we identified 490 significantly differentially methylated CpGs (ADEH+ vs healthy controls, genome-wide). Many of these associated with severity measures, especially eosinophil count (431/490 sites). CONCLUSIONS: We identified a CpG in IL4 associated with serum tIgE levels, supporting a role for Th2 immune mediating mechanisms in AD. Changes in eosinophil level, a measure of disease severity, are associated with methylation changes, providing a potential mechanism for phenotypic changes in immune response-related traits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The main epigenetic studies in AD are related to the DNA methylation of two genes, NLRP2 (involved in macrophage activity) and PITPNM2 (related to neutrophils), both associated with smoking.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Also, the association of eczema herpeticum and serum IgE levels with methylation in the IL-4 and IL-13 genes.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Self-citationAryee, M. J., Jaffe, A. E., Corrada-Bravo, H., Ladd-Acosta, C., Feinberg, A. P., Hansen, K. D., & Irizarry, R. A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu049 · Cited by 4,397
Atopic Dermatitis: Global Epidemiology and Risk Factors
Nutten, S. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000370220 · Cited by 3,055
Bieber, T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074081 · Cited by 1,780
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Beck, L. A., Thaçi, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314768 · Cited by 1,421 · cited 2×
“As previous gene expression studies have identified higher expression of IL4 and IL13 in a specific disease group and have led to a treatment using a monoclonal antibody (dupilumab) to block these molecules [34], our hope is that a similar treatment could arise from the results of this study, in conjunction with furth…”
BackgroundResultSelf-citationAtopic dermatitis: a disease of altered skin barrier and immune dysregulation
Boguniewicz, M., & Leung, D. Y. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01027.x · Cited by 1,073 · cited 2×
“Using a set of 129 CpGs that belong to AD candidate genes of interest (FLG [5, 17, 18, 25, 29, 40], LCE1B [40, 41], RPTN [41, 42], IL4, IL13 [18, 30, 33–35, 40] and its receptors, IFNs [6, 7, 10] and TSLP [13, 14, 18, 30, 40], see Additional file 1 Table Fig.”
BackgroundSelf-citationAccounting for cellular heterogeneity is critical in epigenome-wide association studies
Jaffe, A. E., & Irizarry, R. A. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r31 · Cited by 1,067 · cited 4×
“Jaffe AE, Irizarry RA.”
MethodInfluentialLiu, Y., Aryee, M. J., Padyukov, L., Fallin, M. D., Hesselberg, E., Runarsson, A., Reinius, L., Acevedo, N., Taub, M., Ronninger, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2487 · Cited by 969
Self-citationGlobal variations in prevalence of eczema symptoms in children from ISAAC Phase Three
Odhiambo, J. A., Williams, H. C., Clayton, T. O., Robertson, C. F., & Asher, M. I. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.009 · Cited by 966
The genetics of asthma and allergic disease: a 21st century perspective
Ober, C., & Yao, T. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01029.x · Cited by 698 · cited 1×
“This analysis with adjustment for six default cell types (eosinophils and neutrophils combined as granulocytes) identifies biologically relevant signals strongly associated with different diseases from previous studies [40, 47].”
Method
Cited by
Pathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
“Monoclonal antibodies, including nemolizumab, a humanized monoclonal antibody targeting IL-31 receptor A (IL-31RA), relieve itching symptoms and IL-31 signal transduction in the pathogenesis of AD.”
BackgroundInfluentialEczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L. M., Zeitvogel, J., & Werfel, T. (2021) · Allergy · doi:10.1111/all.14853 · Cited by 116
Genetics and epigenetics of atopic dermatitis: an updated systematic review
Martin, M. J., Estravís, M., García-Sánchez, A., Dávila, I., Isidoro-García, M., & Sanz, C. (2020) · Genes · doi:10.3390/genes11040442 · Cited by 99
“identified a significant association between IL4 and IL13 methylation and the AD phenotype, as well as with serum IgE levels [28].”
BackgroundInfluentialHost methylation predicts SARS-CoV-2 infection and clinical outcome
Konigsberg, I. R., Barnes, B., Campbell, M., Davidson, E., Zhen, Y., Pallisard, O., Boorgula, M. P., Cox, C., Nandy, D., Seal, S., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00042-y · Cited by 84
Self-citationUpdate on the pathogenesis of atopic dermatitis.
Criado, P. R., Miot, H. A., Bueno-Filho, R., Ianhez, M., Criado, R. F. J., & de Castro, C. C. S. (2024) · Anais brasileiros de dermatologia · doi:10.1016/j.abd.2024.06.001 · Cited by 66
Metadata
- Authors
- Boorgula, M. P., Taub, M. A., Rafaels, N., Daya, M., Campbell, M., Chavan, S., Shetty, A., Cheadle, C., Barkataki, S., Fan, J., David, G., Beaty, T. H., Ruczinski, I., Hanifin, J., Schneider, L. C., Gallo, R. L., Paller, A. S., Beck, L. A., Leung, D. Y., Mathias, R. A., & Barnes, K. C.
- Affiliations
- University of Colorado Denver (US)
- Dana-Farber Cancer Institute (US)
- Qiagen (United States) (US)
- Johns Hopkins University (US)
- Rho (United States) (US)
- Oregon Health & Science University (US)
- Boston Children's Hospital (US)
- University of California San Diego (US)
- Northwestern University (US)
- University of Rochester (US)
- National Jewish Health (US)
- Corresponding author
- Barnes, Kathleen C.
- ORCID
- Venue
- Clinical Epigenetics
- Published
- 2019-08-23
- Volume
- 11
- Issue
- 1
- Pages
- 122-122
- ISSN
- 1868-7075 (ISSN-L)
- 1868-7083
- PMC
- PMC6706929
- OpenAlex
- W2969375765
- Semantic Scholar
- 4f3562f8f3695938d51211017a5bc0483b39a9db
- Cited by
- 28
- References
- 58
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 6
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Clinical Epigenetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- NIH/NIAID (U19 AI117673)
- Mary Beryl Patch Turnbull Scholar Program
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- eczema herpeticum, atopic dermatitis, DNA methylation, epigenetics, IL-4, total IgE, eosinophil count, disease severity, Th2 immune response, whole blood
- MeSH terms
- Dermatitis, Atopic, Eosinophils, Female, Humans, Immunoglobulin E, Kaposi Varicelliform Eruption, Male, Severity of Illness Index, Interleukin-4, Case-Control Studies, Th2 Cells, CpG Islands, DNA Methylation, Epigenesis, Genetic, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Replicated methylation changes associated with eczema herpeticum and allergic response. https://app.cochat.ai/papers/10.1186/s13148-019-0714-1
- The paper
- Boorgula, M. P., Taub, M. A., Rafaels, N., Daya, M., Campbell, M., Chavan, S., Shetty, A., Cheadle, C., Barkataki, S., Fan, J., David, G., Beaty, T. H., Ruczinski, I., Hanifin, J., Schneider, L. C., Gallo, R. L., Paller, A. S., Beck, L. A., Leung, D. Y., . . . Barnes, K. C. (2019). Replicated methylation changes associated with eczema herpeticum and allergic response. Clinical Epigenetics. https://doi.org/10.1186/s13148-019-0714-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.